-
2022-503046-50-00
Healthy volunteer trial 2023-09-11
-
2022-502546-26-00
Sickle Cell Disease 2023-09-11
-
2022-502861-78-00
Pharmacokinetic trial 2023-09-08
-
2024-514621-29-00
1. Patients with compensated liver cirrhosis due to any 2023-09-07
-
2023-503332-40-00
Healthy 2023-09-05
-
2023-503541-54-00
Healthy volunteer trial 2023-08-28
-
2023-505228-79-00
RSV (Respiratory Syncytial Virus) 2023-08-28
-
2023-505367-36-00
Healthy 2023-08-24
-
2023-504411-32-00
immune-mediated inflammatory disorders, including ulcer 2023-08-23
-
2023-504281-34-00
Adult patients with advanced solid tumors 2023-08-22
-
2022-503037-63-00
Phase I, Clinical trial in healthy males and females
in 2023-08-17
-
2023-505153-41-00
Not applicable (submitted trial is a study in healthy s 2023-08-17
-
2023-504310-30-00
Healthy volunteers 2023-08-16
-
2023-505881-27-00
ER+/HER2 positive breast cancer 2023-08-14
-
2023-508267-69-00
Subjects with Aadvanced solid tumors for whom life-prol 2023-08-11
-
2022-503047-17-00
Healthy 2023-08-10
-
2023-504260-42-00
No medical condition 2023-08-08
-
2023-503949-65-00
Type 2 Diabetes 2023-08-07
-
2022-502952-30-00
Healthy Adult Participants 2023-08-04
-
2023-504326-19-00
Asthma 2023-08-03
-
2023-504405-37-00
Pharmacokinetic trial in healthy volunteers 2023-08-02
-
2023-503783-16-00
Healthy 2023-08-02
-
2023-505521-14-00
refractory metastatic prostate cancer 2023-08-02
-
2023-506863-32-00
Multiple Sclerosis (MS) 2023-07-25